Related Experiment Video
Updated: Jun 1, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Hypokinetic-rigid syndrome in children and inborn errors of metabolism
A García-Cazorla1, C Ortez, B Pérez-Dueñas
1Department of Neurology, Hospital Sant Joan de Déu, Passeig Sant Joan de Deu 2, 08950 Esplugues, Barcelona, Spain.
Insights
Hypokinetic-rigid syndrome (HRS), or parkinsonism, is uncommon in children. This review guides pediatric neurologists in diagnosing and treating metabolic causes of HRS, highlighting specific genetic conditions and therapeutic approaches.
Area of Science:
- Pediatric Neurology
- Metabolic Disorders
- Neurodegenerative Diseases
Background:
- Hypokinetic-rigid syndrome (HRS), characterized by hypokinesia, bradykinesia, rigidity, and tremor, is rare in children.
- Acquired causes include infections, encephalitis, hypoxia, and drugs; genetic causes primarily involve inborn errors of metabolism (IEM).
- IEM-related HRS often presents with other neurological signs and may improve with targeted therapies.
Purpose of the Study:
- To provide pediatric neurologists with a practical guide for the clinical approach to metabolic HRS.
- To outline diagnostic procedures and treatment strategies for HRS in children.
- To review genetic causes of both dopa-responsive and non-responsive HRS.
Main Methods:
- Review of literature on pediatric hypokinetic-rigid syndrome.
- Focus on inborn errors of metabolism as a significant cause of genetic HRS.
- Discussion of clinical presentation, diagnostic workup, and therapeutic options.
Main Results:
- Key metabolic diseases causing HRS include neurotransmitter defects, metal storage diseases, energy metabolism disorders, and lysosomal diseases.
- Treatment varies, with l-dopa + carbidopa effective for neurotransmitter defects; other conditions like Wilson disease require different interventions.
- Genetic factors are crucial, especially in juvenile parkinsonism, necessitating consideration of dopa-responsive and non-responsive conditions.
Conclusions:
- Metabolic disorders are an important genetic cause of HRS in children.
- Early diagnosis and specific treatments, such as l-dopa, can significantly impact outcomes.
- A comprehensive approach considering various genetic conditions is essential for managing pediatric parkinsonism.
Abstract:
Hypokinetic-rigid syndrome (HRS) or "parkinsonism" is rare in children. From a clinical point of view it is characterised by a group of signs in which hypokinesia (decreased number of movements), bradykinesia (slowness of movements), rigidity and rest tremor are the fundamental traits. Nervous system infections, immunomediated encephalitis, hypoxia and some drugs have been described as acquired or secondary causes of HRS in the paediatric age. Inborn errors of metabolism (IEM) comprise and important group regarding genetic causes. Main diseases causing HRS in children are neurotransmitter (biogenic amines) defects, metal storage diseases, energy metabolism disorders and lysosomal diseases. In general, in IEM, the HRS is associated to other neurological signs such as dykinesias, pyramidal signs, and psychomotor delay, is very rare in the neonatal period, tends to be more frequent in advanced stages of progressive diseases, and may respond to specific therapies. In particular, l-dopa + carbidopa can be a very effective treatment in neurotransmitter defects, whereas other disorders such as Wilson disease and some particular lysosomal disorders have different therapeutic possibilities. Furthermore, other genetic conditions in dopa-responsive and non-responsive HRS should be also considered, especially in juvenile parkinsonism. Through this review, a practical orientation for paediatric neurologists concerning clinical clues, diagnostic procedure and treatment of metabolic HRS will be provided.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Alterations in Muscle Tone lll
Lysosomal Hydrolases
Alterations in Muscle Tone ll
